Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, Martina Brueckmann, Michael Böhm, Vijay K. Chopra, João Pedro Ferreira, James L. Januzzi, Sanjay Kaul, Ileana L. Piña, Piotr Ponikowski, Sanjiv J. Shah, Michele Senni, Ola Vedin, Subodh Verma, Barbara Peil, Stuart J. Pocock, Faiez Zannad, Milton Packer, Stefan D. Anker

Open source

DOI: 10.1161/circulationaha.121.057812
Published: 2022-01-18
Container: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.121.057812,
  title = {Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial},
  author = {Javed Butler and Gerasimos Filippatos and Tariq Jamal Siddiqi and Martina Brueckmann and Michael Böhm and Vijay K. Chopra and João Pedro Ferreira and James L. Januzzi and Sanjay Kaul and Ileana L. Piña and Piotr Ponikowski and Sanjiv J. Shah and Michele Senni and Ola Vedin and Subodh Verma and Barbara Peil and Stuart J. Pocock and Faiez Zannad and Milton Packer and Stefan D. Anker},
  year = {2022},
  journal = {Circulation},
  doi = {10.1161/circulationaha.121.057812},
  url = {https://doi.org/10.1161/circulationaha.121.057812}
}

RIS

TY  - JOUR
TI  - Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
AU  - Javed Butler
AU  - Gerasimos Filippatos
AU  - Tariq Jamal Siddiqi
AU  - Martina Brueckmann
AU  - Michael Böhm
AU  - Vijay K. Chopra
AU  - João Pedro Ferreira
AU  - James L. Januzzi
AU  - Sanjay Kaul
AU  - Ileana L. Piña
AU  - Piotr Ponikowski
AU  - Sanjiv J. Shah
AU  - Michele Senni
AU  - Ola Vedin
AU  - Subodh Verma
AU  - Barbara Peil
AU  - Stuart J. Pocock
AU  - Faiez Zannad
AU  - Milton Packer
AU  - Stefan D. Anker
PY  - 2022
JO  - Circulation
DO  - 10.1161/circulationaha.121.057812
UR  - https://doi.org/10.1161/circulationaha.121.057812
ER  -

APA

Butler, J., Filippatos, G., Siddiqi, T. J., Brueckmann, M., Böhm, M., Chopra, V. K., Ferreira, J. P., Januzzi, J. L., Kaul, S., Piña, I. L., Ponikowski, P., Shah, S. J., Senni, M., Vedin, O., Verma, S., Peil, B., Pocock, S. J., Zannad, F., Packer, M., & Anker, S. D. (2022). Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Circulation. https://doi.org/10.1161/circulationaha.121.057812

Source records

crossref · retrieved 2026-11-10T14:00:35.502Z